Jonathan Ringler
YOU?
Author Swipe
View article: Data from Disulfiram Treatment Facilitates Phosphoinositide 3-Kinase Inhibition in Human Breast Cancer Cells <i>In vitro</i> and <i>In vivo</i>
Data from Disulfiram Treatment Facilitates Phosphoinositide 3-Kinase Inhibition in Human Breast Cancer Cells <i>In vitro</i> and <i>In vivo</i> Open
Frequent genetic alterations of the components in the phosphoinositide 3-kinase (PI3K)/PTEN/AKT signaling pathway contribute greatly to breast cancer initiation and progression, which makes targeting this signaling pathway a promising ther…
View article: Data from Disulfiram Treatment Facilitates Phosphoinositide 3-Kinase Inhibition in Human Breast Cancer Cells <i>In vitro</i> and <i>In vivo</i>
Data from Disulfiram Treatment Facilitates Phosphoinositide 3-Kinase Inhibition in Human Breast Cancer Cells <i>In vitro</i> and <i>In vivo</i> Open
Frequent genetic alterations of the components in the phosphoinositide 3-kinase (PI3K)/PTEN/AKT signaling pathway contribute greatly to breast cancer initiation and progression, which makes targeting this signaling pathway a promising ther…
View article: Supplementary Figures 1-9 from Disulfiram Treatment Facilitates Phosphoinositide 3-Kinase Inhibition in Human Breast Cancer Cells <i>In vitro</i> and <i>In vivo</i>
Supplementary Figures 1-9 from Disulfiram Treatment Facilitates Phosphoinositide 3-Kinase Inhibition in Human Breast Cancer Cells <i>In vitro</i> and <i>In vivo</i> Open
Supplementary Figures 1-9 from Disulfiram Treatment Facilitates Phosphoinositide 3-Kinase Inhibition in Human Breast Cancer Cells In vitro and In vivo
View article: Supplementary Figures 1-9 from Disulfiram Treatment Facilitates Phosphoinositide 3-Kinase Inhibition in Human Breast Cancer Cells <i>In vitro</i> and <i>In vivo</i>
Supplementary Figures 1-9 from Disulfiram Treatment Facilitates Phosphoinositide 3-Kinase Inhibition in Human Breast Cancer Cells <i>In vitro</i> and <i>In vivo</i> Open
Supplementary Figures 1-9 from Disulfiram Treatment Facilitates Phosphoinositide 3-Kinase Inhibition in Human Breast Cancer Cells In vitro and In vivo